Education
About Us
Working with TipRanks
Follow Us
CSPC Pharmaceutical Group Limited (HK:1093)
:1093
Total Valuation
CSPC Pharmaceutical Group has a market cap or net worth of HK$63.73B. The enterprise value is .
Market CapHK$63.73B
Enterprise Value
Share Statistics
CSPC Pharmaceutical Group has 11.54B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11.54B
Owened by Insiders
Owened by Instutions
Financial Efficiency
CSPC Pharmaceutical Group’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 17.20%.
Return on Equity (ROE)19.53%
Return on Assets (ROA)12.69%
Return on Invested Capital (ROIC)17.20%
Return on Capital Employed (ROCE)21.27%
Revenue Per EmployeeHK$1,463,227.02
Profits Per EmployeeHK$273,938.011
Employee Count21,400
Asset Turnover0.75
Inventory Turnover3.25
Valuation Ratios
The current PE Ratio of CSPC Pharmaceutical Group is 13.30. CSPC Pharmaceutical Group’s PEG ratio is 2.16.
PE Ratio13.30
PS Ratio2.26
PB Ratio2.60
Price to Fair Value2.60
Price to FCF34.17
Price to Operating Cash Flow18.69
PEG Ratio2.16
Income Statement
In the last 12 months, CSPC Pharmaceutical Group had revenue of HK$31.31B and earned HK$5.86B in profits. Earnings per share was HK$0.51.
RevenueHK$31.31B
Gross ProfitHK$22.35B
Operating IncomeHK$7.14B
Pretax IncomeHK$7.46B
Net IncomeHK$5.86B
EBITDA8.26B
Earnings Per Share (EPS)0.51
Cash Flow
In the last 12 months, operating cash flow was HK$4.27B and capital expenditures -HK$1.54B, giving a free cash flow of HK$2.73B billion.
Operating Cash FlowHK$4.27B
Free Cash FlowHK$2.73B
Free Cash Flow per ShareHK$0.24
Dividends & Yields
CSPC Pharmaceutical Group pays an annual dividend of HK$0.10, resulting in a dividend yield of 6.83%
Dividend Per ShareHK$0.10
Dividend Yield6.83%
Payout Ratio35.62%
Free Cash Flow Yield2.93%
Earnings Yield7.52%
Stock Price Statistics
Beta0.98
52-Week Price Change-5.71%
50-Day Moving Average4.79
200-Day Moving Average5.24
Relative Strength Index (RSI)67.06
Average Volume (3m)129.09M
Important Dates
CSPC Pharmaceutical Group upcoming earnings date is May 21, 2025, TBA.
Last Earnings DateMar 28, 2025
Next Earnings DateMay 21, 2025
Ex-Dividend DateJun 4, 2025
Financial Position
CSPC Pharmaceutical Group as a current ratio of 2.63, with Debt / Equity ratio of 0.02
Current Ratio2.63
Quick Ratio2.32
Debt to Market Cap<0.01
Net Debt to EBITDA-1.33
Interest Coverage Ratio296.58
Taxes
In the past 12 months, CSPC Pharmaceutical Group has paid HK$1.43B in taxes.
Income TaxHK$1.43B
Effective Tax Rate17.82%
Enterprise Valuation
CSPC Pharmaceutical Group EV to EBITDA ratio is 7.83, with an EV/FCF ratio of 29.22.
EV to Sales1.93
EV to EBITDA7.83
EV to Free Cash Flow29.22
EV to Operating Cash Flow15.98
Balance Sheet
CSPC Pharmaceutical Group has HK$10.81B in cash and marketable securities with HK$388.69M in debt, giving a net cash position of -HK$10.42B billion.
Cash & Marketable SecuritiesHK$10.81B
Total DebtHK$388.69M
Net Cash-HK$10.42B
Net Cash Per Share-HK$0.90
Tangible Book Value Per ShareHK$2.74
Margins
Gross margin is 70.51%, with operating margin of 22.20%, and net profit margin of 16.98%.
Gross Margin70.51%
Operating Margin22.20%
Pretax Margin21.36%
Net Profit Margin16.98%
EBITDA Margin24.66%
EBIT Margin21.43%
Analyst Forecast
The average price target for CSPC Pharmaceutical Group is HK$5.44, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$5.44
Price Target Upside-1.55%
Analyst ConsensusModerate Buy
Analyst Count4
Revenue Growth Forecast
EPS Growth Forecast